THE VOGEL GROUP

Lobbying for HDT BIO CORP · Medical Research Company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Washington · House · Senate · $49,500.00 income · posted Jul 21, 2025

Lobbying activity 3

Health Issues

Issues related to emerging biological threats and drug development

Medical/Disease Research/Clinical Labs

Issues related to emerging biological threats and drug development

Science/Technology

Issues related to emerging biological threats and drug development

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.